PULSE BIOSCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pulse Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2024.
  • Pulse Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.7M, a 21.4% decline year-over-year.
  • Pulse Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$48.5M, a 22% decline year-over-year.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$43.6M, a 24.9% increase from 2022.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$58.1M, a 7.87% increase from 2021.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$63M, a 26.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$48.5M -$13.7M -$2.4M -21.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$46.1M -$11.7M -$1.5M -14.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$44.6M -$10.6M -$1.05M -11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$43.6M -$12.5M -$3.79M -43.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$39.8M -$11.3M +$6.77M +37.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$46.6M -$10.2M +$3.79M +27% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$50.3M -$9.56M +$7.71M +44.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$58.1M -$8.75M +$6.67M +43.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$64.7M -$18M -$3.75M -26.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$61M -$14M +$792K +5.35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$61.8M -$17.3M +$1.25M +6.76% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$63M -$15.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$14.3M -$1.37M -10.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$14.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$18.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$12.9M -$1.16M -9.87% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q4 2019 -$47M -$13.8M -$4.84M -54% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$42.1M -$11.7M -$985K -9.15% Jul 1, 2019 Sep 30, 2019 10-K 2020-03-16
Q2 2019 -$41.2M -$11.4M -$2.2M -24% Apr 1, 2019 Jun 30, 2019 10-K 2020-03-16
Q1 2019 -$39M -$10.1M -$1.41M -16.3% Jan 1, 2019 Mar 31, 2019 10-K 2020-03-16
Q4 2018 -$37.5M -$8.95M -$250K -2.87% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$37.3M -$10.8M -$3.28M -43.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$34M -$9.16M -$2.98M -48.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$31M -$8.67M -$5.47M -171% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$25.6M -$8.7M -$5.89M -210% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$19.7M -$7.49M -$4.72M -171% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$15M -$6.18M -$3.92M -174% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$11M -$3.2M -$1.51M -89.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$9.52M -$2.81M -$1.27M -83% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$8.24M -$2.77M -$1.53M -124% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$6.71M -$2.26M -$1.3M -136% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$5.41M -$1.68M -$941K -127% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$4.47M -$1.54M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-20
Q3 2015 -$1.23M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-20
Q2 2015 -$956K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-20
Q1 2015 -$743K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.